• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155).

作者信息

Caccese Mario, Ceccato Fililppo, Fassan Matteo, Fassina Ambrogio, Padovan Marta, Mammi Isabella, Iacobone Maurizio, Scaroni Carla, Zagonel Vittorina, Lombardi Giuseppe

机构信息

Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, Padova, Italy.

出版信息

Semin Oncol. 2019 Feb;46(1):104-105. doi: 10.1053/j.seminoncol.2018.12.005. Epub 2019 Jan 2.

DOI:10.1053/j.seminoncol.2018.12.005
PMID:30655020
Abstract
摘要

相似文献

1
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155).致编辑的信：对R.T. 凯西的回复（《肿瘤学 Seminars》，2018年6月；45(3):151 - 155）
Semin Oncol. 2019 Feb;46(1):104-105. doi: 10.1053/j.seminoncol.2018.12.005. Epub 2019 Jan 2.
2
Clarification of the FDA Accelerated Agnostic Approval of Pembrolizumab and the Opportunities Arising From the Required Confirmatory Studies-Reply.美国食品药品监督管理局（FDA）对帕博利珠单抗加速无特定生物标志物批准的阐释以及所需确证性研究带来的机遇——回复
JAMA Oncol. 2018 Sep 1;4(9):1300-1301. doi: 10.1001/jamaoncol.2018.1715.
3
MicroRNAs as Onco-miRs, drivers of cancer.作为癌基因miR的微小RNA，癌症的驱动因素。
J Natl Cancer Inst. 2010 Sep 8;102(17):1306-8. doi: 10.1093/jnci/djq349. Epub 2010 Aug 25.
4
Letter to the Editor referring to the manuscript entitled: "Phase II trial of trastuzumab in women with advanced or recurrent HER-positive endometrial carcinoma: a Gynecologic Oncology Group study" recently reported by Fleming et al., (Gynecol Oncol., 116;15-20;2010).致编辑的信，涉及弗莱明等人最近报道的题为《曲妥珠单抗治疗晚期或复发性HER阳性子宫内膜癌女性的II期试验：妇科肿瘤学组研究》的手稿（《妇科肿瘤学》，第116卷，第15 - 20页；2010年）
Gynecol Oncol. 2010 Jul;118(1):95-6; author reply 96-7. doi: 10.1016/j.ygyno.2010.01.043. Epub 2010 Feb 20.
5
Reply to the Letter to the Editor of Dr. Pauwels et al.
Inflamm Bowel Dis. 2019 Apr 11;25(5):e58. doi: 10.1093/ibd/izy274.
6
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.对错配修复缺陷肿瘤进行程序性死亡受体-1阻断治疗
N Engl J Med. 2015 Nov 12;373(20):1979. doi: 10.1056/NEJMc1510353.
7
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.错配修复缺陷肿瘤中的程序性死亡受体-1阻断
N Engl J Med. 2015 Nov 12;373(20):1979. doi: 10.1056/NEJMc1510353.
8
Reply to: letter to the editor "subcutaneous herceptin therapy".回复：致编辑的信“皮下注射赫赛汀治疗”
J Clin Pharmacol. 2013 Dec;53(12):1343-4. doi: 10.1002/jcph.172. Epub 2013 Sep 21.
9
Reply to letter: "regional lymphadenectomy for adrenocortical carcinoma".致信回复：“肾上腺皮质癌的区域淋巴结清扫术”
Ann Surg. 2013 Apr;257(4):e15. doi: 10.1097/SLA.0b013e3182891efb.
10
Reply to the letter to the editor: bimonthly injections of ranibizumab for age-related macular degeneration.
Graefes Arch Clin Exp Ophthalmol. 2015 May;253(5):825. doi: 10.1007/s00417-014-2878-x. Epub 2014 Dec 6.

引用本文的文献

1
The Efficacy and Safety of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis.免疫检查点抑制剂治疗肾上腺皮质癌的疗效与安全性：一项系统评价和Meta分析
Cancers (Basel). 2024 Feb 23;16(5):900. doi: 10.3390/cancers16050900.
2
Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care.晚期肾上腺皮质癌：从症状控制到姑息治疗
Cancers (Basel). 2022 Nov 29;14(23):5901. doi: 10.3390/cancers14235901.
3
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation.
多学科团队评估后，晚期肾上腺皮质癌患者的总生存期和无进展生存期有所提高。
Cancers (Basel). 2022 Aug 12;14(16):3904. doi: 10.3390/cancers14163904.
4
Objective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma with Cabozantinib.卡博替尼治疗晚期肾上腺皮质癌的客观缓解和疾病长期控制
J Clin Endocrinol Metab. 2020 May 1;105(5):1461-8. doi: 10.1210/clinem/dgz318.